Marks IM - Search Results

1

Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals.

Marks IM, Lelliott P, Basoglu M, Noshirvani H, Monteiro W, Cohen D, Kasvikis Y. Marks IM, et al. Br J Psychiatry. 1988 Apr;152:522-34. doi: 10.1192/bjp.152.4.522. Br J Psychiatry. 1988. PMID: 3167404 Clinical Trial.

2

Gender-divergent aetiological factors in obsessive-compulsive disorder.

Noshirvani HF, Kasvikis Y, Marks IM, Tsakiris F, Monteiro WO. Noshirvani HF, et al. Among authors: marks im. Br J Psychiatry. 1991 Feb;158:260-3. doi: 10.1192/bjp.158.2.260. Br J Psychiatry. 1991. PMID: 2012918

3

Obsessive-compulsive beliefs and treatment outcome.

Lelliott PT, Noshirvani HF, Başoğlu M, Marks IM, Monteiro WO. Lelliott PT, et al. Among authors: marks im. Psychol Med. 1988 Aug;18(3):697-702. doi: 10.1017/s0033291700008382. Psychol Med. 1988. PMID: 2903513 Clinical Trial.

4

Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: relations between dose, plasma levels, outcome and side effects.

Kasvikis Y, Marks IM. Kasvikis Y, et al. Among authors: marks im. Psychopharmacology (Berl). 1988;95(1):113-8. doi: 10.1007/BF00212778. Psychopharmacology (Berl). 1988. PMID: 3133689 Clinical Trial.

5

Agoraphobics 5 years after imipramine and exposure. Outcome and predictors.

Lelliott PT, Marks IM, Monteiro WO, Tsakiris F, Noshirvani H. Lelliott PT, et al. Among authors: marks im. J Nerv Ment Dis. 1987 Oct;175(10):599-605. doi: 10.1097/00005053-198710000-00004. J Nerv Ment Dis. 1987. PMID: 3309186 Clinical Trial.

6

Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial.

Monteiro WO, Noshirvani HF, Marks IM, Lelliott PT. Monteiro WO, et al. Among authors: marks im. Br J Psychiatry. 1987 Jul;151:107-12. doi: 10.1192/bjp.151.1.107. Br J Psychiatry. 1987. PMID: 3315086 Clinical Trial.

7

Urinary cortisol during exposure in obsessive-compulsive ritualizers.

Kasvikis YG, Basoglu M, Monteiro W, Marks IM, Lelliott P, Noshirvani H. Kasvikis YG, et al. Among authors: marks im. Psychiatry Res. 1988 Feb;23(2):131-5. doi: 10.1016/0165-1781(88)90002-9. Psychiatry Res. 1988. PMID: 3363021

8

Relationship of skin conductance activity to clinical features in obsessive-compulsive ritualizers.

Lelliott PT, Noshirvani HF, Marks IM, Monteiro WO, Basoglu M, Cohen SD. Lelliott PT, et al. Among authors: marks im. Psychol Med. 1987 Nov;17(4):905-14. doi: 10.1017/s0033291700000714. Psychol Med. 1987. PMID: 3432465

9

Normal dexamethasone suppression test in obsessive-compulsive disorder.

Monteiro W, Marks IM, Noshirvani H, Checkley S. Monteiro W, et al. Among authors: marks im. Br J Psychiatry. 1986 Mar;148:326-9. doi: 10.1192/bjp.148.3.326. Br J Psychiatry. 1986. PMID: 3719227 No abstract available.

10

Safety and side-effects of alprazolam. Controlled study in agoraphobia with panic disorder.

O'Sullivan GH, Noshirvani H, Başoğlu M, Marks IM, Swinson R, Kuch K, Kirby M. O'Sullivan GH, et al. Among authors: marks im. Br J Psychiatry. 1994 Jul;165(1):79-86. doi: 10.1192/bjp.165.1.79. Br J Psychiatry. 1994. PMID: 7802851 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters